Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2026-01-07 @ 3:51 AM
Study NCT ID:
NCT02058160
Status:
COMPLETED
Last Update Posted:
2017-05-09
First Post:
2014-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-06
First Submit QC Date:
None
Study First Post Date:
2014-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-16
Results First Submit QC Date:
None
Results First Post Date:
2017-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-07-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-03-31
Last Update Post Date:
2017-05-09
Last Update Post Date Type:
ACTUAL